SYBX 1.45 (+6.62%)
US87166L1008BiotechnologyBiotechnology

Synlogic (SYBX) Financial Metrics

This table shows a selected set of financial data points of Synlogic (SYBX). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -8.81 0 -0.44 25.03M -0.61 3.37M -51.83M -51.25M -57.28M 23.96M
2022 -13.83 0 -0.05 3.63M -0.46 1.18M -57.62M -63.63M -66.15M 15.86M
2021 -16.42 0 -0.15 8.93M -0.38 1.75M -52.88M -58.12M -60.56M 16.44M
2020 -24.77 0 -0.09 5.16M -0.36 545K -39.95M -56.53M -59.17M 32.51M
2019 -25.45 0 -0.1 5.21M -0.31 2.22M -76.72M -54.41M -51.37M 26.18M
2018 -2.03 0 -3.46 167.42M -0.4 2.52M -48.12M -45.97M -48.44M 11.25M
2017 -6 0 -1.62 65.23M -0.49 2.44M -33.63M -38.01M -40.38M 58.44M
2016 -8.82 0 -1.43 37.51M -0.34 0 -26.53M -26.11M -26.27M 16.43M
2015 -8.4 0 -5.21 130.19M -0.5 0 -21.39M -24.93M -24.98M 89.71M
2014 -19.57 0 0 0 -0.95 0 -14.07M -15.8M -15.83M 9.32M
2013 -5.68 0 0 0 -0.54 0 -6.5M -6.4M -6.44M 23.18M
2012 -4.52 0 0 0 0 0 -4.52M -3.27M -3.66M 0

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.